跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Efergen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Efergen
Approved
STANDARD
Efergen
Azarias Pharmaceutical Laboratories Inc.,
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8e1461daa4e19b6a
Company
Azarias Pharmaceutical Laboratories Inc.,
Type
Standard
Approval Details
Approval Id
8e1461daa4e19b6a
Drug Approval Philippines Name
Efergen
Product Name
Efergen
Registration Number
DRP-16360
Brand Name
Efergen
Generic Name
Multivitamins + Minerals.
Dosage Form
Effervescent Tablet
Dosage Strength
Formulation: Each Effervescent Tablet contains: Ascorbic Acid (Vit. C) Calcium (as calcium carbonate and calcium pantothenate) 500 mg 100 mg Magnesium (as magnesium carbonate heavy and magnesium sulphate) 100 mg 50 mg Nicotinamide (Vit. B3) Pantothenic acid (as calcium Pantothenate) (Vit. B5) 23 mg Thiamine Hydrochloride (Vit. B1) 15 mg Riboflavin (as riboflavin sodium phosphate) (Vit. B2) 15 mg 10 mg 10 mg Pyridoxine Hydrochloride (Vit. B6) Zinc (as zinc citrate dihydrate) Folic Acid Biotin (Vit. H) Cyanocobalamin (Vit. B12)
Manufacturer
Azarias Pharmaceutical Laboratories Inc.,
Issuance Date
28 February 2025
Expiry Date
28 February 2027
Pharmacologic Category
Vitamin & Minerals
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8e1461daa4e19b6a
Type
Standard
Back to Philippines FDA Approvals